BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 14, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Feraheme ferumoxytol regulatory update

AMAG said it received a notice of non-compliance from Health Canada for an NDS for Feraheme ferumoxytol to treat iron deficiency anemia in chronic kidney disease (CKD) patients. According to the biotech, the agency's concerns focused mainly on...

Read the full 169 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >